Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “M Protein”

89 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 89 results

Not applicableWithdrawnNCT05476822
What this trial is testing

Profiling Spike Protein Antibody Response Post COVID-19 Booster

Who this might be right for
COVID-19 BoosterSpike Protein IgG Antibody
David Grant U.S. Air Force Medical Center
Testing effectiveness (Phase 2)UnknownNCT04990544
What this trial is testing

Phase II Clinical Trial of Recombinant SARS-CoV-2 Spike Protein Vaccine (CHO Cell) for the Prevention of COVID-19

Who this might be right for
COVID-19
Shanghai Zerun Biotechnology Co.,Ltd 528
Large-scale testing (Phase 3)Active Not RecruitingNCT05468736
What this trial is testing

Study to Evaluate Safety and Immunogenicity of COVID-19 Vaccine in Children 6 Months to < 12 Years

Who this might be right for
COVID-19
Novavax 3,600
Early research (Phase 1)Study completedNCT05181709
What this trial is testing

A Live Recombinant Newcastle Disease Virus-vectored COVID-19 Vaccine Phase 1 Study.

Who this might be right for
SARS-CoV-2
Sean Liu 35
Not applicableLooking for participantsNCT06082284
What this trial is testing

A Cross-sectional Study on the Positive Rate of M Protein Based on a Highly Sensitive Serum M Protein Detection Method.

Who this might be right for
Multiple MyelomaM Protein
Zhujiang Hospital 10,000
Testing effectiveness (Phase 2)Looking for participantsNCT05939037
What this trial is testing

Zanubrutinib Treatment in Patients With IgM Monoclonal Gammopathy and Antri-MAG Related Polyneuropathy

Who this might be right for
Monoclonal Gammopathy of Uncertain Significance
UMC Utrecht 35
Large-scale testing (Phase 3)Study completedNCT01884311
What this trial is testing

Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases

Who this might be right for
Primary Immune Deficiency DisordersCommon Variable ImmunodeficiencyX-linked Agammaglobulinaemia+1 more
Bio Products Laboratory 38
Early research (Phase 1)UnknownNCT04982068
What this trial is testing

Phase I Clinical Trial of Recombinant SARS-CoV-2 Spike Protein Vaccine (CHO Cell) for the Prevention of COVID-19

Who this might be right for
COVID-19
Shanghai Zerun Biotechnology Co.,Ltd 72
Testing effectiveness (Phase 2)UnknownNCT05239806
What this trial is testing

A Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of SCTV01C and SCTV01E in Population Aged ≥12 Years Previously Fully Vaccinated With Inactivated COVID-19 Vaccine

Who this might be right for
COVID-19SARS-CoV-2 Infection
Sinocelltech Ltd. 400
Testing effectiveness (Phase 2)Looking for participantsNCT06418477
What this trial is testing

Daratumumab, Bortezomib, Cyclophosphamide, and Dexamethasone Therapy for Patients with MIDD

Who this might be right for
Monoclonal Gammopathy of Renal Significance
Peking University People's Hospital 20
Not applicableStudy completedNCT05251896
What this trial is testing

Plasma-free Replacement in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Zhongnan Hospital 119
Not applicableLooking for participantsNCT07020741
What this trial is testing

Stable Isotopes- Adults With Obesity

Who this might be right for
Obese Patients (BMI ≥ 30 kg/m²)Glucose MetabolismProtein Metabolism
University of Illinois at Urbana-Champaign 8
Not applicableUnknownNCT01425606
What this trial is testing

Pseudohyponatremia of Multiple Myeloma is True Hyponatremia

Who this might be right for
Hyponatremia of Multiple Myeloma
Meir Medical Center 50
Testing effectiveness (Phase 2)Study completedNCT01998633
What this trial is testing

Reduced Intensity Conditioning for Hemophagocytic Syndromes or Selected Primary Immune Deficiencies (BMT CTN 1204)

Who this might be right for
Hemophagocytic LymphohistiocytosisChronic Active Epstein-Barr Virus InfectionChronic Granulomatous Disease+3 more
Medical College of Wisconsin 47
Testing effectiveness (Phase 2)Ended earlyNCT03634800
What this trial is testing

Radiotherapy With Immunotherapy for Systemic Effect in Myeloma (RISE-M)

Who this might be right for
Multiple Myeloma
Weill Medical College of Cornell University 6
Testing effectiveness (Phase 2)UnknownNCT05238454
What this trial is testing

A Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of SCTV01C in Population Aged ≥18 Years and Previously Fully Vaccinated With COVID-19 Vaccine

Who this might be right for
COVID-19SARS-CoV-2 Infection
Sinocelltech Ltd. 600
Not applicableUnknownNCT02933021
What this trial is testing

Unravel MGUS (Monoclonal Gammopathy of Unknown Significance)

Who this might be right for
Monoclonal Gammopathy of Unknown Significance
RxCelerate Ltd 664
Testing effectiveness (Phase 2)UnknownNCT02519114
What this trial is testing

Haploidentical Bone Marrow Stem Cell Transplantation in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Maastricht University Medical Center 24
Testing effectiveness (Phase 2)Study completedNCT04566276
What this trial is testing

ChulaCov19 Vaccine in Healthy Adults

Who this might be right for
COVID-19 VaccineSafety Issues
Chulalongkorn University 192
Testing effectiveness (Phase 2)Study completedNCT05112848
What this trial is testing

Evaluate Safety and Immunogenicity of a COVID-19 Vaccine in People Living With HIV at Risk for SARS-CoV-2 (COVID-19)

Who this might be right for
SARS-CoV-2 Infection
Novavax 384
Load More Results